Control group:Intravaginal administration of recombinant human interferon alpha 2b vaginal effervescent capsules (cinfenine).
Sponsors
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Conditions
HPV
Early Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high risk
Active, not recruitingITMCTR2000003652
Start: 2020-10-01Updated: 2023-02-20
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high risk
Active, not recruitingChiCTR2000035837
Start: 2020-10-01Updated: 2020-08-24